Kirkland & Ellis LLP and NautaDutilh N.V. have advised Pharvaris N.V. Sidley Austin LLP and Loyens & Loeff N.V. have advised the underwriters. Pharvaris N.V. (Nasdaq:...
Pharvaris Prices $115 Million Underwritten Offering of Ordinary Shares
Immunovant Raises $550 Million in Common Stock Offering
Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
Immuneering Prices $175 Million Public Offering and $25 Million Private Placement
Latham & Watkins has advised Immuneering Corporation on the offering, and Sidley Austin has advised Leerink Partners and Oppenheimer & Co. Immuneering Corporation has announced the...
Pharvaris Announces US$201.2 Million Public Offering of Shares and Pre-Funded Warrants
NautaDutilh N.V. and Kirkland & Ellis LLP have advised Pharvaris N.V. on the offering, and Sidley Austin LLP and Loyens & Loeff N.V. have advised underwriters....
Klaviyo’s $372.9 Million Common Stock Offering
Goodwin Procter advised Klaviyo, Inc. on the offering, and Sidley Austin represented the underwriters in the offering. Klaviyo, Inc. (“Klaviyo” or the “Company”) (NYSE: KVYO) announced...
Supira Medical’s $120 Million Series E Financing Round
Sidley Austin LLP represented Supira Medical, Inc. in the transaction. Supira Medical, Inc. (Supira), a clinical-stage company, announced it has closed an oversubscribed Series E financing...
Contego Medical’s U.S. Distribution Agreement with Medtronic
Sidley Austin represented Contego Medical, Inc. in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Medtronic. Medtronic plc, the leading global healthcare technology company,...
Contineum Therapeutics’ $110 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters. Contineum Therapeutics, a clinical stage biopharmaceutical company,...
Pyxis Oncology’s $50 Million Shares Private Placement
Sidley Austin represented Pyxis Oncology, Inc. on the deal. Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company, announced that it agreed to sell 8,849,371 shares of...
Praxis Precision Medicines’ $264 Milion Collaboration and License Agreement with Tenacia Biotechnology
Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered...
Klaviyo’s $576 Million Initial Public Offering
Goodwin Procter advised Klaviyo, and Sidley Austin advised the underwriters on the offering. Klaviyo, Inc. announced the pricing of its initial public offering of 19,200,000 shares of...
IO Biotech’s $75 Million Private Placement Financing
Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents. IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive...